NFKB1 and COVID-19: Multiple evidences showed that increased ACE2 levels and NF-κB downstream cytokine levels were presented in patients with severe COVID-19 symptom (Pinto et al., 2020; Soy et al., 2020; Zhuang et al., 2020; Rabaan et al., 2021).